Literature DB >> 17874041

Toward Mycobacterium tuberculosis DXR inhibitor design: homology modeling and molecular dynamics simulations.

Nidhi Singh1, Mitchell A Avery, Christopher R McCurdy.   

Abstract

Mycobacterium tuberculosis 1-deoxy-D: -xylulose-5-phosphate reductoisomerase (MtDXR) is a potential target for antitubercular chemotherapy. In the absence of its crystallographic structure, our aim was to develop a structural model of MtDXR. This will allow us to gain early insight into the structure and function of the enzyme and its likely binding to ligands and cofactors and thus, facilitate structure-based inhibitor design. To achieve this goal, initial models of MtDXR were generated using MODELER. The best quality model was refined using a series of minimizations and molecular dynamics simulations. A protein-ligand complex was also developed from the initial homology model of the target protein by including information about the known ligand as spatial restraints and optimizing the mutual interactions between the ligand and the binding site. The final model was evaluated on the basis of its ability to explain several site-directed mutagenesis data. Furthermore, a comparison of the homology model with the X-ray structure published in the final stages of the project shows excellent agreement and validates the approach. The knowledge gained from the current study should prove useful in the design and development of inhibitors as potential novel therapeutic agents against tuberculosis by either de novo drug design or virtual screening of large chemical databases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874041     DOI: 10.1007/s10822-007-9132-0

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  51 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Protein structure prediction and structural genomics.

Authors:  D Baker; A Sali
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

3.  Isopentenyl diphosphate biosynthesis via a mevalonate-independent pathway: isopentenyl monophosphate kinase catalyzes the terminal enzymatic step.

Authors:  B M Lange; R Croteau
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 4.  Protein structure--based drug design.

Authors:  P J Whittle; T L Blundell
Journal:  Annu Rev Biophys Biomol Struct       Date:  1994

5.  Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate.

Authors:  Sebabrata Mahapatra; Tetsuya Yagi; John T Belisle; Benjamin J Espinosa; Preston J Hill; Michael R McNeil; Patrick J Brennan; Dean C Crick
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

6.  Characterization of 1-deoxy-D-xylulose 5-phosphate reductoisomerase, an enzyme involved in isopentenyl diphosphate biosynthesis, and identification of its catalytic amino acid residues.

Authors:  T Kuzuyama; S Takahashi; M Takagi; H Seto
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

7.  Prediction of the three-dimensional structure of human interleukin-7 by homology modeling.

Authors:  R T Kroemer; S W Doughty; A J Robinson; W G Richards
Journal:  Protein Eng       Date:  1996-06

8.  The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.

Authors:  Aengus Mac Sweeney; Roland Lange; Roberta P M Fernandes; Henk Schulz; Glenn E Dale; Alice Douangamath; Philip J Proteau; Christian Oefner
Journal:  J Mol Biol       Date:  2005-01-07       Impact factor: 5.469

9.  Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain.

Authors:  Keun Woo Lee; James M Briggs
Journal:  Proteins       Date:  2004-03-01

10.  Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.

Authors:  B Heym; N Honoré; C Truffot-Pernot; A Banerjee; C Schurra; W R Jacobs; J D van Embden; J H Grosset; S T Cole
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

View more
  4 in total

1.  Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis: Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes.

Authors:  Jérôme de Ruyck; Johan Wouters; C Dale Poulter
Journal:  Curr Enzym Inhib       Date:  2011-07

2.  Homology modeling of Mycobacterium tuberculosis 2C-methyl-D-erythritol-4-phosphate cytidylyltransferase, the third enzyme in the MEP pathway for isoprenoid biosynthesis.

Authors:  Cristian Obiol-Pardo; Alex Cordero; Jaime Rubio-Martinez; Santiago Imperial
Journal:  J Mol Model       Date:  2009-11-15       Impact factor: 1.810

Review 3.  Molecular docking as a popular tool in drug design, an in silico travel.

Authors:  Jerome de Ruyck; Guillaume Brysbaert; Ralf Blossey; Marc F Lensink
Journal:  Adv Appl Bioinform Chem       Date:  2016-06-28

4.  Conformational dynamics of the flexible catalytic loop in Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.

Authors:  Sarah L Williams; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2009-01       Impact factor: 2.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.